D. E. Shaw & Co., Inc. Intra Cellular Therapies, Inc. Call Options Transaction History

D. E. Shaw & Co., Inc.

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q4 2020 Feb 16, 2021	SELL	$23.34 - $32.22 $583,500 - $805,500	-25,000 Reduced 50.0%	25,000 $795,000
Q4 2019 Feb 14, 2020	BUY	$7.26 - $38.49 $363,000 - $1.92 Million	50,000 New	50,000 $1.72 Million

378

84.7M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $8.05B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.